retatrutide phase 2 nejm 2023 obesity trial jastreboff Early data for demonstrates exceptional weight loss results, reaching approximately 21% placebo-adjusted weight loss by week 48. This performance significantly exceeds all other leading medications currently under GLP-1 Medications for Weight Loss:

With BCBS, Shapely patients can access medical weight loss support, including virtual visits with licensed providers, dietitian-led coaching, and prescriptions for weight loss medications

This reduces discomfort and potential irritation, and decreases the incidence of broken brackets by 49%* on average

Mistake 5: Ignoring hormonal signals Missed periods, significant cycle irregularity, or symptoms of estrogen deficiency during rapid weight loss should be communicated to a healthcare provider

Avoid the inner thigh where blood vessels are closer to the surface

GLP-1 has anti-apoptotic effects in vivo , and its promotion of cells expressing the GLP-1 receptor directly resists -cell apoptosis (Drucker, 2003)